• Recently presented study demonstrates statistically significant benefits for patient outcomes using the NervAlign® Nerve Cuff
• Patients with the Nerve Cuff experienced major decrease in post-surgery pain compared to those without
• 93% of patients with the Nerve Cuff said they would elect to have surgery again vs. 70% without

ReNerve Limited (ASX:RNV), a medical device company developing novel peripheral nerve repair products, announced the highly positive results from a recent nerve repair comparative study. The results show that patients benefit from the use of the NervAlign® Nerve Cuff compared to those who do not have the Nerve Cuff incorporated in their treatment, reporting significantly lower post-surgery measures of pain. Furthermore, as an indication of patient satisfaction post-surgery, patients who were treated with the Nerve Cuff were more likely to indicate they would have their procedure again than those that were not treated with the Nerve Cuff. The study data has been presented at the American College of Foot and Ankle Surgeons (ACFAS 2025) Annual Conference. The NervAlign® Nerve Cuff is designed for the protection of repaired and regenerating nerves during the healing process after peripheral nerve injuries or repair surgery. The study examined the use of the NervAlign® Nerve Cuff in peripheral nerve repair surgeries and used two end points - the first being an independent pain score assessment using the Visual Analogue Scale (VAS) methodology, measured pre- and post-surgery; and the second being whether the patient would elect to have the procedure again following the surgery and their recovery period. The results demonstrate the significant benefits of using the NervAlign® Nerve Cuff in peripheral nerve repair surgery, with patients who underwent surgery with the Nerve Cuff experiencing a significant decrease in post-surgery pain compared to those who did not use the Nerve Cuff.